LG Life Science to distribute Sancuso exclusively.
Published: 2007-08-16 06:58:00
Updated: 2007-08-16 06:58:00
LG Life Science announced on Aug. 10 that the company made a technical licence agreement with ProStrakan Group, a UK pharmaceutical company for an exclusive distribution of Sancuso, a patch form of anti-vomiting drug, in Korea.
ProStrakan filed the registration of Sancuso to the U. S. FDA in ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
